Leaflet FLUORORINIL 0.1% / 0.05% inhalation suspension
Indicated for: allergic rhinitis; urticaria
Route of administration: inhalation
Substance: chlorpheniramine maleate + betamethasone (antiallergic agent + glucocorticoid)
ATC: R01ADN1 (Respiratory system | Decongestants and other nasal preparations for topical use | Corticosteroids)
This medicine may affect your ability to drive or use machines.
Use caution if you have glaucoma or increased eye pressure.
May cause dry mouth, constipation, urinary retention, or blurred vision.
This medicine may increase blood sugar.
This medicine may increase the risk of infections.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Do not stop treatment abruptly without medical advice.
This medicine may cause drowsiness or reduced alertness.
This combination of chlorpheniramine maleate and betamethasone is used for the treatment of allergic and inflammatory conditions such as allergic rhinitis, urticaria, atopic dermatitis, or other severe allergic reactions. Chlorpheniramine reduces allergic symptoms, while betamethasone combats inflammation and excessive immune responses.
It is taken orally as directed by a doctor, usually in tablet form. It is intended for short-term use during acute episodes to minimize the risk of side effects associated with corticosteroids.
Common side effects include drowsiness, dizziness, dry mouth (due to chlorpheniramine), increased appetite, fluid retention, or hyperglycemia (due to betamethasone).
This combination is contraindicated in patients with untreated systemic infections, glaucoma, uncontrolled diabetes, or severe hypertension. It should be used with caution in children, as corticosteroids may affect growth.
Patients should strictly follow their doctor’s instructions and avoid alcohol consumption, which may enhance the sedative effects of chlorpheniramine.
General data about FLUORORINIL 0.1% / 0.05%
- Substance: chlorpheniramine maleate + betamethasone
- Date of latest medicines list: 01-07-2013
- Product code: W02161001
- Concentration: 0.1% / 0.05%
- Pharmaceutical form: inhalation suspension
- Quantity: 10
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.